drugset / Trial / NCT05603598

LEAP2 on Postprandial Glucose Metabolism and Food Intake n Obese Males

NCT05603598 ↗

RandomizedCrossoverDouble-blindBasic science

Summary

The study aims to delineate the effects of the naturally occurring peptide liver-enriched antimicrobial peptide 2 (LEAP-2) on postprandial glucose metabolism and food intake in obese volunteers. The overall objective is to investigate the physiological importance of LEAP-2 in obese subjects.

Timeline

Start
2022-08-24
Primary completion
2023-05-01
Completion
2023-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject LEAP2 Peptide — Intravenous

Indications